Results 171 to 180 of about 61,152 (267)

Targeting Multiple Gut‐Brain Pathways in Obesity: Rationale for Combination Pharmacotherapy

open access: yesObesity Science &Practice, Volume 12, Issue 2, April 2026.
ABSTRACT Background As a disease of energy dysregulation, obesity involves metabolic, hormonal, and neural factors, the interconnection of which is referred to as the “gut‐brain axis.” Objective This review aimed to provide an overview of the clinical evidence of physiological and objective or subjective changes in eating behavior with gut hormone ...
Alexander D. Miras, Muzamil Hussain
wiley   +1 more source

Intra-mitochondrial sorting of precursor proteins [PDF]

open access: yes, 1993
Brown, Alistair J. P.   +3 more
core   +1 more source

Holding vs Continuing GLP-1/GIP Agonists Before Upper Endoscopy: The OCULUS Randomized Clinical Trial.

open access: yesJAMA Intern Med
Ahmad AI   +13 more
europepmc   +1 more source

The Effects of SGLT2 Inhibitors on Muscle Health in Older Adults: A Systematic Review and Meta‐Analysis

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 2, April 2026.
SGLT2 inhibitors reduce skeletal muscle mass modestly in older adults with type 2 diabetes. Forest plot (a) and count our funnel plot (b) show a small but significant pooled reduction in muscle mass (SMD = −0.36, 95% CI [−0.56, −0.15]; I2 = 24.1%), with weight loss occurring predominantly through fat mass reduction.
Weena Joongpan   +5 more
wiley   +1 more source

Life-course influence of birthweight and subsequent pathways on healthy aging: a Mendelian randomization study. [PDF]

open access: yesBMC Med
Kong L   +16 more
europepmc   +1 more source

The Mitochondrial Protein Import Apparatus [PDF]

open access: yes, 1990
Neupert, Walter, Pfanner, Nikolaus
core   +1 more source

OSA Endotyping as Targets for Treatment. How Far Have We Come?

open access: yesRespirology, Volume 31, Issue 4, Page 339-351, April 2026.
ABSTRACT Obstructive sleep apnoea (OSA) is highly prevalent and is associated with significant impairments in quality of life and comorbidity. The most common treatment employed is continuous positive airway pressure (CPAP), especially in moderate and severe cases.
Walter T. McNicholas   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy